Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy

Management of high-grade gliomas (HGGs) remains a complex challenge with an overall poor prognosis despite aggressive multimodal treatment. New translational research has focused on maximizing tumor cell eradication through improved tumor cell targeting while minimizing collateral systemic side effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Loya, Joshua, Zhang, Charlie, Cox, Emily, Achrol, Achal S, Kesari, Santosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880300/
https://www.ncbi.nlm.nih.gov/pubmed/31747784
http://dx.doi.org/10.2217/cns-2019-0002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880300/
https://www.ncbi.nlm.nih.gov/pubmed/31747784
http://dx.doi.org/10.2217/cns-2019-0002

Ejemplares similares